A new goldmarker for visualization of organs during

A new goldmarker for visualization of
organs during radiotherapy.
GOLDLOCK® is, a new unique goldmarker, developed for visualisation of
the prostate during planning, simulation and treatment of prostate cancer. By inserting the goldmarkers in
the prostate, an accurate position of
the organ helps to reduce the margins during external radiotherapy,
thus minimising the risk of affecting
adjacent organs.
·
·
·
·
Proven, safe material
Easy to insert
Stays in the organ
Cost effective
Features:
• Package of 1, 3, and 4 preloaded needles
• ”Star-shaped” design
• Needle with a pusher to pull out the goldmarker
Specification:
• 24-carat gold with different sizes
• Needle length: 20cm
• Single use, sterile, with a shelf-life of over 2 years
Ordering
Goldlock® I
Goldlock® III
Goldlock® IV
Product no: 5250-04
Product no: 5250-05
Product no: 5250-06
(1 needle, 20cm, 1x3mm)
(3 needles, 20cm, 1x3mm)
(4 needles, 20cm, 1x3mm)
Goldlock® I (XB)
Goldlock® III (XB)
Goldlock® IV (XB)
Product no: 5250-07
Product no: 5250-08
Product no: 5250-09
(1 needle, 20cm, 1,2x3mm)
(3 needles, 20cm, 1,2x3mm)
(4 needles, 20cm, 1,2x3mm)
Goldlock® III (XS)
Product no: 5250-14
(3 needles, 20cm, 0,8x3mm)
(1 needle, 20cm, 2 pcs 1x3mm)
(1 needle, 20cm, 2 pcs 1,2x3mm)
Beampoint AB · Kista Science Tower. SE-164 51 Kista, Sweden
Sweden: Phone: +46 8 751 01 75 Fax: +46 8 35 00 83. Finland: Phone: +358 408 287 899. Fax: +358 8370 044
www.beampoint .se
0434
TF-PB-02, version 2
Goldlock® I dual
Product no: 5250-21
Goldlock® I dual (XB) Product no: 5250-22